Chemoinformaics analysis of 37-hydroxy-hexatetracont-1-en-15-one
| Molecular Weight | 675.224 | nRot | 43 |
| Heavy Atom Molecular Weight | 584.504 | nRig | 2 |
| Exact Molecular Weight | 674.694 | nRing | 0 |
| Solubility: LogS | -7.812 | nHRing | 0 |
| Solubility: LogP | 16.443 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 138 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 48 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 90 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 46 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 138.435 |
| nHD | 1 | BPOL | 91.1566 |
| QED | 0.052 |
| Synth | 2.998 |
| Natural Product Likeliness | 0.545 |
| NR-PPAR-gamma | 0.194 |
| Lipinski | Rejected |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.002 |
| HIA | 0.008 |
| CACO-2 | -5.642 |
| MDCK | 0.000000882 |
| BBB | 0 |
| PPB | 1.05141 |
| VDSS | 3.621 |
| FU | 0.00190649 |
| CYP1A2-inh | 0.009 |
| CYP1A2-sub | 0.092 |
| CYP2c19-inh | 0.048 |
| CYP2c19-sub | 0.034 |
| CYP2c9-inh | 0.004 |
| CYP2c9-sub | 0.987 |
| CYP2d6-inh | 0.006 |
| CYP2d6-sub | 0.024 |
| CYP3a4-inh | 0.107 |
| CYP3a4-sub | 0.004 |
| CL | 4.798 |
| T12 | 0.006 |
| hERG | 0.529 |
| Ames | 0.005 |
| ROA | 0.001 |
| SkinSen | 0.99 |
| Carcinogencity | 0.008 |
| EI | 0.904 |
| Respiratory | 0.319 |
| NR-Aromatase | 0.016 |
| Antiviral | Yes |
| Prediction | 0.628032 |